Teri is joining the team at the National Hemophilia Foundation to launch, lead and manage the new Pathway to Cures (P2C) National Hemophilia Foundation Venture Fund, LLC focused on project specific and equity investments in companies developing therapies for inheritable blood diseases. Teri has been in the business of commercializing early-stage research results for over 35 years and most recently as the founding managing director of IU Ventures’ Indiana Philanthropic Venture Fund. Teri served as a senior executive for business development for Cold Spring Harbor Laboratory, Mount Sinai School of Medicine in NYC, was the founding chief executive of Cambridge Enterprise Ltd in Cambridge England and a co-founder of ARCH development partners an early-stage Midwest venture fund.
Her career has been about starting, re-organizing and leading technology transfer programs and launching new early-stage funds that invest in science-based ventures. She has been an advisor to policy makers, universities and companies, is a past President of the Association of University Technology Managers (AUTM), a former Bye Fellow of Christ’s College Cambridge in England and an Indiana Sagamore of the Wabash.
Teri lives in Bloomington Indiana with her partner Richard McConnel who is retired from the University of Cambridge. Together they have six children and four grandchildren who live in various places in England, Scotland and the US.
Renee leads the fundraising initiatives for Pathway to Cures with a focus on supporting equity investments in companies developing therapies for inheritable blood diseases.
For over 25 years, she has been advancing the mission of non-profits through strategic fundraising and communication initiatives. Organizations have greatly benefitted from Renee’s fundraising expertise including Providence Health System, Ascension St. John Foundation, Corewell Health’s Beaumont Foundation, Detroit PAL, and Henry Ford Health. Additionally, she has done medical research for Henry Ford Health and the Barbara Ann Karmanos Cancer Institute.
Renee has a Bachelor of Science in Biology from Western Michigan University and a Masters in Community Medicine and Healthcare Administration from Wayne State University School of Medicine. Her community service includes volunteering with Avalon Healing Center, Alternatives for Girls, and Elite Detection K9 as well as previous roles with other non-profits.
She resides in Rochester Hills, Michigan with her husband of 24 years, Trevor, and their two Brittany spaniels: Cooper & Otus. She loves spending time with her friends and family as well as gardening, hiking, kayaking, and traveling.
Tim has been involved in the bleeding disorders community since 2004. He serves as
Sr. Director of Business Development for the National Hemophilia Foundation and Pathway to Cures. Tim provides deal sourcing activities, maintains prospect lists for existing and new investments, contracts oversight, platform management, and operational support.
His previous experience includes clinic and pharmacy operations management and national accounts contracting for a national specialty pharmaceutical distributor. For over 15 years, he has been supporting and advising governing boards of various not-for-profit organizations with which he has been affiliated.
Tim holds a Master of Business Administration degree from Eastern Illinois University.
For over three decades I treated families with bleeding disorders, working towards finding better treatments for patients and preventing complications of their disorders through education, advocacy, and research. My work was most gratifying when I could help someone realize his or her full potential, living a life not limited by a diagnosis or its complications. Diagnosing and treating boys and girls, men and women, parents, grandparents and family members was fulfilling personally and professionally. Conducting clinical and laboratory research helped me to understand how to develop and elevate treatments to new levels, seeking cures and improving the quality of life for everyone in the bleeding disorders community. I have spent time in the biopharmaceutical industry trying to understand how to bring new therapies to patients globally. My past experiences as a physician, educator, researcher, and an industry partner have all focused on treating patients and their families and have provided me with the experiences and knowledge to take on this challenging role as the President and CEO for the National Hemophilia Foundation, a role I take on behalf of the entire bleeding disorders community and one that I see as the pinnacle of my career – serving you.
The landscape of the bleeding disorders community is changing and there are challenges ahead. Gene therapy and novel technologies and treatments bring new opportunities, and many questions as well. We will face these challenges together, working jointly to find solutions. Through collaboration with patients, families, chapters, partners, supporters, medical professionals, patient organizations, government agencies, and all stakeholders in the bleeding disorders community, everything is possible. I believe in unity, and my past leadership roles in these areas put us in a unique position to move forward in ways we haven’t had the opportunity to do so ever before. To unlock our greatest potential in such an exciting time we must all support each other – this is what will define our success.
This is an exciting time for the bleeding disorders community as research is progressing forward in unimaginable ways, but there is still more to be done. This is why one of my primary objectives will be to increase our funding to support innovative research on new therapies, and then educating stakeholders on these advancements. Advocating on behalf of those impacted by bleeding disorders with our legislators locally and in Washington D.C. for better access, including access to care, to treatment centers, to physicians, and to new treatments will be ever more important.
I look forward to working with you in our joint pursuit to improve the outcomes for our community.
Peter Harvey serves as the Chief Business Officer for NHF including oversight for finance & accounting, business development, conference & travel services, payer relations, and IT. Peter is a senior healthcare finance and operations executive with diverse experience in healthcare nonprofit finance & accounting, pharma/biotech HEOR and medical affairs business operations, academic medical/pediatric department and Hemophilia Treatment Center administration, plus PM&R medical practice and research foundation executive leadership. Peter has volunteered at a number of non-profits and is a founding volunteer board member of a nonprofit providing education and humanitarian support to children and families in Mariani, Haiti. He has a B.A. in Biology from Augustana College and a M.B.A. from the University of Chicago, Booth School of Business in Finance and Healthcare.
Dawn has been a leader in the bleeding disorders community for many years. As a parent of a son with hemophilia, she founded the Rocky Mountain Hemophilia & Bleeding Disorders Association in Bozeman, Montana, served as its Executive Director, and began their Family Camp. After moving to Pittsburgh, Pennsylvania, Dawn worked for the American Diabetes Association (ADA) as an Area Manager. Concurrently, she served as a board member for the Hemophilia Center of Western Pennsylvania for six years. Dawn left the ADA for a position as the Executive Director of the Western Pennsylvania Chapter of the NHF in Pittsburgh, where she became actively involved with Camp Hot to Clot and eventually became the Director. She holds a Bachelor of Science from Montana State University in Bozeman.
Brett is an innovative nonprofit executive with more than 20 years of experience in the healthcare nonprofit field. As the Vice President of Advancement, Brett leads theNHF’s development, communications, marketing, and walk programs. Brett possesses significant experience in fundraising, including annual fund programs, major gifts, corporate and foundation development, special event fundraising, capital campaigns, and planned giving efforts. He has created and managed successful communications initiatives, including marketing, media relations and social media development, along with board governance and structure. Brett previously held leadership positions at Autism Speaks, The Alzheimer’s Association, The ARC, The American Society for Parenteral and Enteral Nutrition, and the American College of Cardiology. He is also actively involved with the American Society of Association Executives, the Association of Fundraising Professionals, The Center for Nonprofit Excellence, and Board Source. Brett attended George Mason University, where he completed his undergraduate and graduate work in communications and public administration.